Agreement Expands on the Companies' Collaboration for the Preclinical Development of Poten...

Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine – Yahoo Finance

Agreement Expands on the Companies' Collaboration for the Preclinical Development of Potential Anti-Cancer TherapiesTORRANCE, Calif., Oct. 12, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical…

 

Read the full article here


-- END RSP MOD -->